Abstract
AbstractHypertension, characterised by a constant high blood pressure, is the primary risk factor for multiple cardiovascular events and a major cause of death in adults. Excitingly, innovations in high-throughput technologies have enabled the global exploration of the whole genome (genomics), revealing dysregulated genes that are linked to hypertension. Moreover, post-genomic biomarkers, from the emerging fields of transcriptomics, proteomics, glycomics and lipidomics, have provided new insights into the molecular underpinnings of hypertension. In this paper, we review the pathophysiology of hypertension, and highlight the multi-omics approaches for hypertension prediction and diagnosis.
Publisher
Springer Science and Business Media LLC
Reference111 articles.
1. World Health Organisation. Cardiovascular diseases 2021. Retrieved from https://www.who.int/health-topics/hypertension#tab=tab_1.
2. Olsen MH, Angell SY, Asma S, Boutouyrie P, Burger D, Chirinos JA, et al. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. Lancet. 2016;388:2665–712.
3. Kumar V, Abbas AK, Aster JC Robbins basic pathology e-book: Elsevier Health Sciences; 2017.
4. Morgado J, Sanches B, Anjos R, Coelho C. Programming of essential hypertension: what pediatric cardiologists need to know. Pediatr Cardiol. 2015;36:1327–37.
5. Patel RS, Masi S, Taddei S. Understanding the role of genetics in hypertension. Eur Heart J. 2017;38:2309–12.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献